InsiderClue
← All stocks

Rapport Therapeutics, Inc.

RAPP Scheduled selling only
CIK 0002012593 #1932 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$3.86M
$3.86M on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 7 sales
Net
−$3.86M
$0.00 against sales at will

By person

9 insiders · 7 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Yeleswaram Krishnaswamy
Chief Development Officer
—
$2.55M (4) scheduled
−$2.55M
195,862
0.4082%
$9.01M
−32.7%
Ceesay Abraham
Chief Executive Officer
—
$1.31M (3) scheduled
−$1.31M
582,164
1.21%
$26.79M
−28.2%
Third Rock Ventures V, L.P. entity
10% owner
—
—
—
6,280,525
13.09%
$289.00M
−12.0%
Bredt David
Chief Scientific Officer
—
—
—
393,075
0.8193%
$18.09M
−23.5%
Gault Cheryl
Chief Operating Officer
—
—
—
149,914
0.3125%
$6.90M
−5.1%
PAUL STEVEN M
Director
—
—
—
41,666
0.0868%
$1.92M
—
Huber Reid M
Director
—
—
—
20,400
0.0425%
$938.70K
—
Ignelzi Troy A.
Chief Financial Officer
—
—
—
10,000
0.0208%
$460.15K
—
Young Wendy B.
Director
—
—
—
9,500
0.0198%
$437.14K
—

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Ceesay Abraham
8 Sep 2026
Chief Executive Officer
Sold on a plan
1,069
$46.01
$49.19K
Ceesay Abraham
8 Sep 2026
Chief Executive Officer
Sold on a plan
7,141
$45.56
$325.31K
Yeleswaram Krishnaswamy
25 Aug 2026
Chief Development Officer
Sold on a plan
16,201
$51.06
$827.18K
Yeleswaram Krishnaswamy
25 Aug 2026
Chief Development Officer
Sold on a plan
20,799
$50.31
$1.05M
Ceesay Abraham
25 Aug 2026
Chief Executive Officer
Sold on a plan
18,921
$49.57
$937.96K
Yeleswaram Krishnaswamy
24 Aug 2026
Chief Development Officer
Sold on a plan
13,160
$50.00
$657.98K
Yeleswaram Krishnaswamy
19 Aug 2026
Chief Development Officer
Sold on a plan
404
$49.90
$20.16K

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 10 Jun 2024